Could simply see it as a gravy train. I personally don't believe so and hope these people are joining based on what they see in the science and trials, but it's not to say they move around for other reasons, IMU being cashed up could open opportunities to advance CV's for a year or two regardless of outcome. Just playing devils advocate. Everything is speculation until we see some black and white undisputable results. So many trials, so few results.
Ann: Imugene Appoints Dr John Byon as SVP Clinical Development, page-30
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |